UTI AMC Q4 Performance Review: Reports Loss At ₹66.7 Crore

By Kotak News Desk
|
24 Apr 2026 at 11:05 AM IST
|
Market News
|
4m

Stay updated with the latest stock market developments and trends.

You can set Kotak Neo as a preferred source to receive regular market updates.

Summary

UTI Asset Management Company reported Q4 FY26 results. Reports a loss at ₹66.7 crore, revenue and EBITDA sharply lower. AUM increased 14% to ₹3.88 lakh crore.

Recently, the UTI Asset Management Company announced its Jan-March quarter results, reporting a significant drop in net profit.

According to the exchange filings, the company reported a net loss of ₹66.7 crore on a consolidated basis, compared with a net profit of ₹120.9 crore in the previous period.

The UTI Asset Management Company shares declined to ₹1,035.95, marking a decline of 2.46% on the 23 April 2026 trading session.

Key Details Of The Q4 Results

In the latest quarter, the UTI Asset Management Company registered a decline of 24.5% quarter-on-quarter (QoQ) in revenue. The revenue stood at ₹390 crore against ₹517 crore in Q3 FY26.

Also, the earnings before interest, taxes, depreciation, and amortisation (EBITDA) of the company dropped from ₹302.2 crore in Q3 FY26 to ₹12.21 crore in Q4 FY26.

Other Important Highlights

The asset under management (AUM) of the company increased by 14% to ₹3.88 lakh crore. Equity assets rose 5% to ₹95,824 crore from ₹90,863 crore. Hybrid assets grew 9% to ₹34,232 crore, while fixed income assets increased 6% to ₹38,088 crore from ₹36,023 crore.

Cash arbitrage assets climbed 9% to ₹43,653 crore, and passive funds saw a sharper 25% rise to ₹1.77 lakh crore from ₹1.41 lakh crore.

Systematic investment plan (SIP) inflows advanced 17% to ₹852 crore compared with ₹731 crore, while AUM expanded 6% to ₹39,813 crore.

Also Read - Coforge Wraps Up Encora Deal, Raises $550 Million Via Loan

Dividend

The company’s board recommended a final dividend of ₹40 per equity share for the financial year 2025-2026.

Sources:

Company Release

ETnow

Business Line

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.

About the Author